Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Queensland Health
AstraZeneca
Julphar
Daiichi Sankyo
Medtronic
Johnson and Johnson
US Department of Justice
Fish and Richardson
McKinsey

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,839,342

« Back to Dashboard

Summary for Patent: 4,839,342
Title: Method of increasing tear production by topical administration of cyclosporin
Abstract:The present invention provides a method of treating an aqueous-deficient dry eye state in a patient suffering therefrom, which method includes the step of administering cyclosporin topically to the patient's eye. The cyclosporin is administered as a solution, suspension or ointment in a pharmaceutically acceptable excipient.
Inventor(s): Kaswan; Renee (Athens, GA)
Assignee: University of Georgia Research Foundation, Inc. (Athens, GA)
Application Number:07/092,466
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 4,839,342

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,839,342

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 109970 ➤ Subscribe
Australia 2421388 ➤ Subscribe
Australia 620048 ➤ Subscribe
Canada 1335566 ➤ Subscribe
Germany 3851152 ➤ Subscribe
Denmark 54390 ➤ Subscribe
European Patent Office 0391909 ➤ Subscribe
Spain 2012116 ➤ Subscribe
Greece 1000558 ➤ Subscribe
Greece 880100578 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Fish and Richardson
Teva
US Department of Justice
Federal Trade Commission
Chinese Patent Office
Healthtrust
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot